Medirom Healthcare Technologies Inc. (NASDAQ:MRM – Get Free Report) saw a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 2,779 shares, a decline of 78.6% from the September 15th total of 13,001 shares. Based on an average trading volume of 20,358 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are sold short.
Medirom Healthcare Technologies Trading Down 16.2%
Shares of NASDAQ MRM traded down $0.09 during mid-day trading on Tuesday, reaching $0.45. The company had a trading volume of 61,561 shares, compared to its average volume of 244,715. Medirom Healthcare Technologies has a 52 week low of $0.37 and a 52 week high of $2.85. The business’s 50-day moving average is $0.84 and its 200-day moving average is $1.00.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Medirom Healthcare Technologies in a research report on Tuesday, August 25th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company has an average rating of “Sell”.
Medirom Healthcare Technologies Company Profile
Medirom Healthcare Technologies Inc is a Japan-based healthcare and wellness company that provides relaxation, body-care and preventive-health services. Its core business operates under the Re.Ra.Ku brand, a network of studios offering services such as relaxation treatments, stretching and other wellness programs intended to support customers’ physical well-being.
The company also develops digital preventive-healthcare products and services. These initiatives include wearable technology designed to collect health-related data and support ongoing wellness management, including the MOTHER Bracelet, a device marketed as a low-maintenance activity and health-monitoring wearable.
Medirom serves customers primarily in Japan through its physical locations and technology-based healthcare offerings.
See Also
- Five stocks we like better than Medirom Healthcare Technologies
- A Silent Winner: Texas Instruments Anchors the AI Supercycle
- Amazon’s $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?
- Enlisting Capital: Wolfspeed’s Defense Deal
- Ag Equipment’s Recovery Trade Meets Washington’s Scrutiny
Receive News & Ratings for Medirom Healthcare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medirom Healthcare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
